Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01912651 · ClinicalTrials.gov registry record · Phase 4
The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
A Phase 4 study of Facial Defect, sponsored by University of Michigan.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 300
- Enrollment target
- 1
- Study location
NCT01912651 is a Phase 4 study of Facial Defect that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 300 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01912651, a Phase 4 study of Facial Defect, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
Antibiotics are sometimes prescribed to patients who have had reconstructive surgery of wounds on their face using skin grafts. But, it is not yet known whether antibiotics improve the healing of skin grafts and reduce the risk of infections after surgery in these patients. It is known that antibiotics, like all medications, have side-effects although these are rare. This research study is designed to show us whether antibiotics improve wound healing or not, so that we may determine if we should continue using antibiotics even if they have side-effects in some patients. Our hypothesis is that patients treated with post-operative, systemic antibiotics will demonstrate a statistically significant improvement in the survival of their facial full thickness skin grafts compared to patients who are not treated with systemic antibiotics.
Conditions Studied
Interventions
- DRUG cephalexin
Study Locations (1)
Michigan
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2013-07 |
| Est. Completion | 2028-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01912651
The ClinicalTrials.gov registry entry for NCT01912651 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Facial Defect appearing as the primary indexed condition, and to 1 intervention - of which cephalexin is the first listed.
NCT01912651 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT01912651 about?
NCT01912651 is a clinical study titled "The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery". Antibiotics are sometimes prescribed to patients who have had reconstructive surgery of wounds on their face using skin grafts. But, it is not yet known whether antibiotics improve the healing of skin grafts and reduce the risk of infections after surgery in these patients. It is known that antibiot...
What is the current status of trial NCT01912651?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 300 participants. The study started on 2013-07. Estimated completion is 2028-09.
What conditions does trial NCT01912651 study?
This clinical trial studies the following conditions: Facial Defect.
What interventions are being tested in trial NCT01912651?
The interventions under investigation include: cephalexin (DRUG).
Who is sponsoring clinical trial NCT01912651?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01912651 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Facial Defect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.